Docetaxel: all 1,319 studies that test it
Page 13 of 14. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.
- Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast CancerCompletedNCT00055861Phase 2
- Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck CancerCompletedNCT00055770Phase 1/2
- Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of RelapseCompletedNCT00055731Phase 3
- Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast CancerCompletedNCT00054587Phase 3
- Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal JunctionCompletedNCT00054457Phase 2
- Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung CancerTerminatedNCT00054184Phase 3
- S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00054054Phase 2
- Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast CancerTerminatedNCT00053911Phase 3
- Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00052845Phase 2
- Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast CancerCompletedNCT00052169Phase 2
- Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung CarcinomaCompletedNCT00051571Phase 2
- Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate CancerCompletedNCT00050596Phase 2
- Thalidomide and Docetaxel in Treating Patients With Advanced CancerCompletedNCT00049296Phase 1
- Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00049283Phase 1
- Bortezomib and Docetaxel in Treating Patients With Advanced Solid TumorsTerminatedNCT00049088Phase 1
- Iressa/Docetaxel in Non-Small-Cell Lung CancerWithdrawnNCT00048087Phase 2
- This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.CompletedNCT00047840Phase 2
- Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast CancerCompletedNCT00047255Phase 3
- Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone TherapyCompletedNCT00046826Phase 2
- Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00045448Phase 1
- Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate CancerCompletedNCT00045227Phase 2
- Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast CancerCompletedNCT00044993Phase 2
- ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing TaxotereStatus unknownNCT00043576Phase 2/3
- Docetaxel in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00041093Phase 2
- Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerCompletedNCT00040807Phase 2
- Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast CancerCompletedNCT00039520Phase 2
- Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate CancerCompletedNCT00038194Phase 1
- Combination Chemotherapy in Treating Women With Resected Breast CancerStatus unknownNCT00033683Phase 2
- Ketoconazole Plus Docetaxel to Treat Prostate CancerCompletedNCT00032825Phase 1
- Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the UterusCompletedNCT00031629Phase 2
- Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate CancerCompletedNCT00031187Phase 2
- Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLCCompletedNCT00030810Phase 2
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerCompletedNCT00030654Phase 3
- Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung CancerStatus unknownNCT00030641Phase 2/3
- Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00030420Phase 2
- Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00030407Phase 2
- Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast CancerTerminatedNCT00028483Phase 2
- S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00026156Phase 2
- Docetaxel and Ifosfamide in Treating Women With Metastatic Breast CancerStatus unknownNCT00026078Phase 2
- S0029 Docetaxel in Treating Older Women With Metastatic Breast CancerTerminatedNCT00025493Phase 2
- Docetaxel in Treating Patients With Non-Small Cell Lung CancerStatus unknownNCT00022022Phase 3
- Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid LeukemiaCompletedNCT00021242Phase 2
- Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00020332Phase 1/2
- Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate CancerCompletedNCT00020046Phase 2
- Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast CancerCompletedNCT00017095Phase 3
- Flavopiridol and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00016185Phase 1
- Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate CancerCompletedNCT00016107Phase 2
- S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast CancerCompletedNCT00015938Phase 2
- Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With SurgeryCompletedNCT00015886Phase 2
- Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00014456Phase 1
- S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung CancerTerminatedNCT00014196Phase 2
- Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the PancreasCompletedNCT00012220Phase 2
- Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast CancerStatus unknownNCT00010140Phase 3
- Docetaxel in Treating Patients With Metastatic Breast CancerCompletedNCT00008411Phase 3
- Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00008125Phase 1
- Vinorelbine and Docetaxel in Treating Women With Metastatic Breast CancerCompletedNCT00006682Phase 2
- Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00006215Phase 2
- Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast CancerStatus unknownNCT00006120Phase 2
- Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00006107Phase 1
- Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00006104Phase 2
- Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach CancerCompletedNCT00006038Phase 2
- Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver CancerCompletedNCT00006010Phase 2
- Docetaxel and Carboplatin in Treating Women With Metastatic Breast CancerCompletedNCT00005963Phase 2
- Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyStatus unknownNCT00005960Phase 2
- Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium CancerStatus unknownNCT00005958Phase 2
- Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung CancerCompletedNCT00005868Phase 2
- Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone TherapyCompletedNCT00005857Phase 2
- Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005810Phase 2
- Doxorubicin and Docetaxel in Treating Women With Stage III Breast CancerCompletedNCT00005800Phase 2
- Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005627Phase 1
- Docetaxel in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00005096Phase 2
- Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder CancerCompletedNCT00005086Phase 2
- Docetaxel and Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00004923Phase 1/2
- Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00004913Phase 1
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerCompletedNCT00004906Phase 2
- MS 209 Plus Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00004886Phase 1
- Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerCompletedNCT00004884Phase 2
- Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00004864Phase 1
- Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung CancerStatus unknownNCT00004264Phase 1/2
- Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid TumorCompletedNCT00004243Phase 1
- Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or StomachCompletedNCT00004235Phase 2
- Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder CancerCompletedNCT00004223Phase 2
- Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast CancerCompletedNCT00004175Phase 2
- Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the NasopharynxStatus unknownNCT00004164Phase 2
- Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00004139Phase 2
- Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph NodesCompletedNCT00004125Phase 3
- Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial TumorsCompletedNCT00004082Phase 1
- Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00004081Phase 2
- Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue SarcomaCompletedNCT00004066Phase 2
- Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal CancerTerminatedNCT00004037Phase 2
- S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00004001Phase 3
- Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial CancerCompletedNCT00003998Phase 3
- Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast CancerCompletedNCT00003953Phase 2
- S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00003908Phase 2
- Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung CancerCompletedNCT00003900Phase 2
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00003888Phase 3
- Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the EsophagusCompletedNCT00003864Phase 2
- Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the PancreasCompletedNCT00003810Phase 2
- Docetaxel in Treating Patients With Stage IV Prostate CancerCompletedNCT00003781Phase 2
- Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00003762Phase 2